loadpatents
Patent applications and USPTO patent grants for Gibeau; Craig R..The latest application filed is for "pyrrolotriazine inhibitors of irak4 activity".
Patent | Date |
---|---|
Tricyclic compounds as inhibitors of mutant IDH enzymes Grant 10,508,108 - Fischer , et al. Dec | 2019-12-17 |
Pyrrolotriazine inhibitors of IRAK4 activity Grant 10,329,295 - Lim , et al. | 2019-06-25 |
Pyrazolopyrimidine inhibitors of IRAK4 activity Grant 10,329,294 - Lim , et al. | 2019-06-25 |
Carboxamide inhibitors of IRAK4 activity Grant 10,155,765 - Lim , et al. Dec | 2018-12-18 |
Pyrrolopyridazine inhibitors of IRAK4 activity Grant 10,040,798 - Lim , et al. August 7, 2 | 2018-08-07 |
Thienopyrazine inhibitors of IRAK4 activity Grant 10,040,802 - Lim , et al. August 7, 2 | 2018-08-07 |
Inhibitors of IRAK4 activity Grant 9,969,749 - Altman , et al. May 15, 2 | 2018-05-15 |
Inhibitors of IRAK4 activity Grant 9,943,516 - Altman , et al. April 17, 2 | 2018-04-17 |
Inhibitors of IRAK4 activity Grant 9,932,350 - Altman , et al. April 3, 2 | 2018-04-03 |
Inhibitors of IRAK4 activity Grant 9,926,330 - Altman , et al. March 27, 2 | 2018-03-27 |
Carboxamide Inhibitors Of Irak4 Activity App 20180051027 - LIM; JONGWON ;   et al. | 2018-02-22 |
Thienopyrazine Inhibitors Of Irak4 Activity App 20180051035 - LIM; JONGWON ;   et al. | 2018-02-22 |
Pyrrolopyridazine Inhibitors Of Irak4 Activity App 20180051029 - LIM; JONGWON ;   et al. | 2018-02-22 |
Pyrazolopyrimidine Inhibitors Of Irak4 Activity App 20180051028 - LIM; JONGWON ;   et al. | 2018-02-22 |
Pyrrolotriazine Inhibitors Of Irak4 Activity App 20180051030 - LIM; JONGWON ;   et al. | 2018-02-22 |
Novel Tricyclic Compounds As Inhibitors Of Mutant Idh Enzymes App 20170369507 - Christian; Fischer ;   et al. | 2017-12-28 |
Novel Tricyclic Compounds As Inhibitors Of Mutant Idh Enzymes App 20170362220 - Fischer; Christian ;   et al. | 2017-12-21 |
Inhibitors Of Irak4 Activity App 20170275297 - ALTMAN; MICHAEL D. ;   et al. | 2017-09-28 |
Inhibitors Of Irak4 Activity App 20170247388 - ALTMAN; MICHAEL D. ;   et al. | 2017-08-31 |
Inhibitors Of Irak4 Activity App 20170217981 - ALTMAN; MICHAEL D. ;   et al. | 2017-08-03 |
Inhibitors Of Irak4 Activity App 20170209446 - ALTMAN; MICHAEL D. ;   et al. | 2017-07-27 |
Aminopyrimidinones as interleukin receptor-associated kinase inhibitors Grant 9,221,809 - Seganish , et al. December 29, 2 | 2015-12-29 |
Substituted piperidines as HDM2 inhibitors Grant 9,062,071 - Ma , et al. June 23, 2 | 2015-06-23 |
SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF App 20140336222 - Bogen; Stephane L. ;   et al. | 2014-11-13 |
Substituted Piperidines As Hdm2 Inhibitors App 20140323482 - Ma; Yao ;   et al. | 2014-10-30 |
Substituted piperidines that increase p53 activity and the uses thereof Grant 8,859,776 - Bogen , et al. October 14, 2 | 2014-10-14 |
Substituted Piperidines That Increase P53 Activity And The Uses Thereof App 20120208844 - Bogen; Stephane L. ;   et al. | 2012-08-16 |
Substituted piperidines that increase P53 activity and the uses thereof Grant 7,884,107 - Ma , et al. February 8, 2 | 2011-02-08 |
Substituted Piperidines that Increase P53 Activity and the Uses Thereof App 20080004287 - Ma; Yao ;   et al. | 2008-01-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.